{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:24:31Z","timestamp":1787495071712,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinbiochem.2024.110803","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T19:39:50Z","timestamp":1721763590000},"page":"110803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical laboratory test utilization of CSF oligoclonal bands and IgG index in a tertiary pediatric hospital"],"prefix":"10.1016","volume":"131-132","author":[{"given":"Rachel K.","family":"Vanderschelden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Shurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110803_b0005","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: Pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110803_b0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0883073819845827","article-title":"Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature","volume":"34","author":"Jeong","year":"2019","journal-title":"J. Child Neurol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110803_b0015","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0883073812452784","article-title":"Pediatric multiple sclerosis","volume":"27","author":"Bigi","year":"2012","journal-title":"J. Child Neurol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110803_b0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110803_b0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110803_b0030","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1177\/1352458519863781","article-title":"Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children in a real-life cohort","volume":"26","author":"Hacohen","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0035","first-page":"618","article-title":"Intrathecal IgG synthesis: when is determination of oligoclonal bands necessary?","volume":"66","author":"Kaiser","year":"1995","journal-title":"Nervenarzt"},{"key":"10.1016\/j.clinbiochem.2024.110803_b0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1468-1331.2005.00997.x","article-title":"Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases","volume":"12","author":"Mayringer","year":"2005","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110803_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The Cerebrospinal Fluid in Multiple Sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110803_b0055","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1212\/NXI.0000000000000573","article-title":"CSF parameters associated with early MRI activity in patients with MS","volume":"6","author":"Klein","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110803_b0060","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1212\/01.WNL.0000144352.67102.BC","article-title":"CSF characteristics in early-onset multiple sclerosis","volume":"63","author":"Pohl","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110803_b0065","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1038\/s41598-021-97543-6","article-title":"Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study","volume":"11","author":"McKay","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0070","doi-asserted-by":"crossref","unstructured":"Chabas D NJ, Belman A, Yeh EA, Kuntz N, Gorman MP, et al. Younger children with MS have a distinct CSF inflammatory profile at disease onset. 2010;74:399-405.","DOI":"10.1212\/WNL.0b013e3181ce5db0"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110803_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-020-01824-2","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110803_b0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12974-020-01825-1","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clinbiochem.2024.110803_b0085","unstructured":"Simone CG EP. Transverse Myelitis 2023."},{"issue":"18","key":"10.1016\/j.clinbiochem.2024.110803_b0090","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/01.wnl.0000260609.11357.6f","article-title":"Acute transverse myelitis in childhood: center-based analysis of 47 cases","volume":"68","author":"Pidcock","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2024.110803_b0095","unstructured":"Anilkumar AC FL, Tadi P. Acute Disseminated Encephalomyelitis 2023."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110803_b0100","article-title":"Acute Disseminated Encephalomyelitis: Current Perspectives","volume":"7","author":"Paolilo","year":"2020","journal-title":"Children (Basel)"},{"key":"10.1016\/j.clinbiochem.2024.110803_b0105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/B978-0-444-52910-7.00048-9","article-title":"Acute disseminated encephalomyelitis","volume":"112","author":"Tenembaum","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110803_b0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110803_b0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","article-title":"Autoimmune encephalitis: clinical spectrum and management","volume":"21","author":"Uy","year":"2021","journal-title":"Pract. Neurol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110803_b0120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-Mediated Encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"Pt 7","key":"10.1016\/j.clinbiochem.2024.110803_b0130","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2024.110803_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","article-title":"CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis","volume":"268","author":"Jarius","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbi.2021.08.006","article-title":"Cerebrospinal fluid test results and associations with subsequent mental disorders, neurological diseases, and CNS infections: A population-based cohort study","volume":"98","author":"Orlovska-Waast","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110803_b0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-8749.2012.04443.x","article-title":"Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology","volume":"55","author":"Sinclair","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.clinbiochem.2024.110803_b0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2019.03.002","article-title":"Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study","volume":"97","author":"Boesen","year":"2019","journal-title":"Pediatr. Neurol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:10:06Z","timestamp":1725901806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"alternative-id":["S0009912024000973"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110803","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical laboratory test utilization of CSF oligoclonal bands and IgG index in a tertiary pediatric hospital","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110803"}}